IQVIA Holdings

$169.87
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$2.13 (-1.24%) Today
$0.00 (0.00%) As of 6:00 PM EST after-hours

Why Robinhood?

You can buy or sell IQVIA Holdings and other stocks, options, and ETFs commission-free!

About IQV

IQVIA Holdings, Inc. operates as a biotechnology company. It engages in healthcare development in the provision of professional services, information technology, and partnering solutions. It operates through the following segments: Technology & Analytics Solutions, Research & Development Solutions and Contract Sales & Medical Solutions. Technology & Analytics Solutions segment provides mission critical information, technology solutions and real world solutions and services to the firm's life science clients. Research & Development Solutions segment, which primarily serves biopharmaceutical customers, provides outsourced clinical research and clinical trial related services. Contract Sales & Medical Solutions segment provides health care provider (including contract sales) and patient engagement services to both biopharmaceutical customers and the broader healthcare market. The company was founded by Dennis B. Gillings and Gary Koch in 1982 and is headquartered in Durham, NC. The listed name for IQV is IQVIA Holdings Inc.

CEO
Ari Bousbib
Employees
67,000
Headquarters
Durham, North Carolina
Founded
1982
Market Cap
32.57B
Price-Earnings Ratio
189.95
Dividend Yield
Average Volume
846.50K
High Today
$171.85
Low Today
$169.38
Open Price
$171.62
Volume
817.07K
52 Week High
$180.77
52 Week Low
$81.79

Collections

IQV Earnings

$0.00
$0.58
$1.16
$1.74
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Feb 10, Pre-Market

You May Also Like